homehealthcare News

Zydus Lifesciences receives USFDA approval for generic drug

healthcare | Dec 2, 2022 2:45 PM IST

Zydus Lifesciences receives USFDA approval for generic drug

Mini

The drug firm has received final approval from the US Food and Drug Administration (USFDA) to market the drug in multiple strengths, the company said in a regulatory filing.

Zydus Lifesciences on Friday said it has received approval from the US health regulator to market Estradiol Transdermal System, used to treat moderate to severe symptoms of menopause, in the American market. The drug firm has received final approval from the US Food and Drug Administration (USFDA) to market the drug in multiple strengths, the company said in a regulatory filing.

Recommended Articles

View All

The medication is indicated to treat moderate to severe symptoms of menopause, which includes feelings of warmth in the face, neck and chest or sudden strong feelings of heat, hot flushes and vaginal dryness in women.
The drug will be manufactured at Zydus group’s formulation manufacturing facility at Moraiya, Ahmedabad.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Tags